Stakeholder economics
Who benefits, who pays, who carries implementation risk, and where incentives are aligned or fragmented.
Market access intelligence
Digital Health Market Access Intelligence
Understand who decides, what evidence they require, and how a digital health solution moves from interest to funded adoption.
The decision context
A strong solution does not create its own route to reimbursement and adoption
Digital health market access sits across clinical value, reimbursement, procurement, regulation, workflow fit, and stakeholder incentives. The decisive barrier is often not product performance but a mismatch between the evidence offered and the evidence a local buyer needs.
Galen Growth maps the market-access landscape around a defined solution and use case, revealing the decision makers, funding routes, evidence standards, and partnerships that can accelerate adoption.
What Galen Growth evaluates
Evidence organised around the decision
Evidence expectations
Clinical, economic, operational, and real-world evidence required by payors, providers, and other decision makers.
Access mechanisms
Reimbursement routes, procurement models, pilots, formularies, distribution, and strategic partnership options.
Adoption friction
Workflow integration, data governance, regulatory status, implementation burden, and local capability gaps.
HealthTech Alpha evidence
Market access viewed through real adoption signals
HealthTech Alpha records show how comparable ventures have built evidence, secured regulatory milestones, formed partnerships, and entered healthcare markets. We use those signals to identify workable access patterns and expose assumptions that have not yet been validated.
- Buyer and payor landscape
- Reimbursement and procurement routes
- Clinical and economic evidence signals
- Comparable partnership pathways
Methodology
From question to defensible action
- Define the access question
Specify the use case, target population, care pathway, buyer, and commercial model.
- Map decision makers
Identify the organisations and stakeholders that approve, fund, influence, implement, and use the solution.
- Benchmark precedents
Analyse comparable ventures, access routes, evidence packages, and partnerships in the target market.
- Build the pathway
Set out the actions, evidence gaps, partner roles, and decision points required to reach adoption.
Related case studies
How Galen Growth has supported these decisions
Sourcing Digital Health in OMICS
A Regional insurance company wanted to identify innovative solutions and business models within the OMICS realm that are tackling Oncology and Wellness.
Finding research solutions in Oncology
A large pharmaceutical player sought oncology ventures that could offer advice, patient cohorts, or clinical trials capabilities, in LATAM, Middle East & Asia
Related research
Evidence behind the market
Sectors
Designed for healthcare decisions
- Biopharma
- Medical device
- Health systems
- Insurance and payors
- Digital health ventures
FAQ
Common questions
What does digital health market access include?
It includes the reimbursement, procurement, evidence, regulatory, workflow, and stakeholder conditions that determine whether a solution can achieve funded adoption.
Does every digital health product need reimbursement?
No. Some solutions are funded through enterprise budgets, employer benefits, consumer payment, partnerships, or other procurement models. The analysis identifies the route that fits the use case and buyer.
Can market access intelligence support launch planning?
Yes. It can clarify evidence gaps, prioritise stakeholders, identify access partners, and sequence the work required before commercial launch.
Related capabilities
Explore other decision areas
Your decision context
Bring us the question that needs a defensible answer.
We will help define the evidence, scope, and practical route from analysis to action.